Olympus Receives FDA Clearance for Advanced EDOF Endoscopy Technology to Enhance GI Lesion Detection
核心洞察
Olympus received FDA 510(k) clearance for its EZ1500 series endoscopes featuring Extended Depth of Field (EDOF) technology, representing the company's most advanced imaging innovation.
The EDOF technology (搜索) uses dual prisms to create continuously sharp images across varying depths, allowing entire lesions to remain in focus during gastrointestinal tract inspection.
The new endoscopes offer improved performance with 3mm close-distance viewing compared to 5mm in previous generation scopes, reducing the need to switch between imaging modes.
Olympus announced FDA 510(k) clearance for its EZ1500 series endoscopes featuring Extended Depth of Field (EDOF) technology, marking a significant advancement in gastrointestinal imaging capabilities. The cleared devices include the GIF-EZ1500 gastroscope (搜索) and CF-EZ1500DL/I colonoscope (搜索), which represent the company's most advanced imaging technology as part of the EVIS X1 endoscopy system (搜索).
Revolutionary Imaging Technology
The EDOF technology (搜索) addresses a fundamental challenge in endoscopic imaging by creating continuously sharp images across varying depths. The system uses two prisms to split light entering the endoscope lens into separate beams with near- and far-focused images. These beams are then projected simultaneously onto an image sensor, combining them into a single image with an extended depth of field.
This technological advancement allows physicians to obtain sharp images while keeping entire lesions in focus, potentially aiding in detection as endoscopists inspect the mucosal lining of the gastrointestinal tract. Compared to previous generation Olympus scopes, the EDOF technology (搜索) provides improved visibility and reduced blurring.
Enhanced Performance Specifications
The EZ1500 series demonstrates measurable improvements over previous endoscope generations. The new scopes allow for closer distance viewing in normal mode at 3mm compared to 5mm in the CF-HQ190L/I model, without experiencing blurring. This enhancement limits the need for physicians to switch between normal and near imaging modes during procedures.
The endoscopes also feature a redesigned ErgoGrip control section that is 10% lighter than the 190 series scope control section. The ergonomic design includes a rounded handle and strategically positioned angulation control knobs and switches to accommodate users with smaller hands while supporting improved scope maneuverability.
Integrated Advanced Imaging Capabilities
When connected to the EVIS X1 CV-1500 video system center, the new endoscopes are compatible with multiple advanced imaging technologies. These include Texture and Color Enhancement Imaging (TXI), designed to increase visibility of lesions and polyps by enhancing image color and texture, and Red Dichromatic Imaging (RDI), which enhances visibility of deep blood vessels and bleeding points.
The system also supports Narrow Band Imaging (NBI) technology, which enhances visual observation of mucosal and vascular patterns by utilizing specific blue and green wavelengths absorbed by hemoglobin. Additionally, Brightness Adjustment Imaging with Maintenance of Contrast (BAI-MAC) technology corrects brightness levels in dark areas while maintaining lighter area brightness to increase total distance view.
Clinical Impact and Market Position
"As a leading global MedTech company, Olympus remains committed to providing advanced options to help physicians offer their patients the best care possible," said Kurt Heine, Senior Vice President and General Manager for Gastrointestinal Solutions at Olympus Corporation. "Our goal is to elevate the standard of endoscopy, and Extended Depth of Field (EDOF) technology represents Olympus' most advanced scope technology to help physicians drive the best clinical outcomes for advancing gastrointestinal procedures."
The EVIS X1 endoscopy system (搜索) aims to revolutionize gastrointestinal disorder detection, characterization, and treatment through innovative diagnostic and therapeutic technologies combined with improved scope handling capabilities. The company emphasizes that the TXI, RDI, BAI-MAC, and NBI technologies serve as adjunctive tools for endoscopic examination to supplement white light imaging, rather than replacing histopathological sampling for diagnostic purposes.